Nifedipine Articles
Four drugmakers to pay $124 million for submission of false claims to USA’s Medicaid
20 October 2009
Bayer Yakuhin aiming for $2.06B annual sales
31 March 2009
Study shows no benefit for widely-used pre-term drug
1 December 2008
Actavis opens R&D laboratory in Florida
10 November 2008
NHI price cuts hit Bayer Yakuhin results
23 April 2007
Adalat demonstrates additional CV benefits
9 April 2007
Headlines 25 years ago this week....
12 February 2007
Headlines 25 years ago this week....
29 January 2007
Schering AG buy boosts Bayer but charges take toll on profit; 3rd-qtr beats forecasts
4 December 2006
Bayer Yakuhin sees 2005 sales rise 4%
1 May 2006
Headlines 25 years ago this week....
13 March 2006
Bayer Healthcare looks set to expand in Japan
18 April 2005
Bayer's Adalat efficacy shown in ACTION trial
28 March 2005
Future of parallel drug trade in enlarged Europe
20 December 2004
Bayer and Schering-Plough form strategic pharmaceuticals alliance
20 September 2004
Pycnogenol reduces need for antihypertensives
8 March 2004
PI traders tell EC: "fight on" after Bayer ruling
5 January 2004
Bayer defeats EU in parallel imports case
5 January 2004
Euro Court opinion backs Bayer over PIs
2 June 2003
Drugs
2 June 2003
Profits up at Bayer on acquisition benefits
12 May 2003
Elan reaches settlements with FTC re-Biovail
8 July 2002
Tokyo pharma stocks - week to May 27
3 June 2002
Merck KGaA to launch nifedipine XL in Brazil
21 November 2001
Unprecedented growth forecast for generics
18 June 2001
Biovail claims patent victory over Bayer
10 April 2001
Mylan takes issue with Biovail's ANDA approval for nifedipine
14 February 2001
Teva launches MS drug Copaxone in UK
7 December 2000
Biovail gets US OK for first generic Adalat CC
5 December 2000
Operating income up 31% at Bayer
10 August 2000
Ca blockers vs diuretics, "no clear benefit"
1 August 2000
Biovail gains tentative OK for nifedipine generic
27 July 2000
Bayer sues generics firms over Adalat CC
11 May 2000
Elderly-use drug price rises "above inflation"
28 April 2000
Bayer structure to remain intact UPDATE
20 March 2000
Stock Commentary New York
9 March 2000
Canada's Isotechnika to test transplant drug
10 February 2000
Pfizer sues FDA over Mylan Procardia OK
23 December 1999
Bayer launches new antihypertensive in Hungary
25 November 1999
Bayer looking to Japan or the USA for a partner instead of Europe
17 November 1999
Bayer chief executive satisfied with first-half 1999 results
12 August 1999
Elan gets US approval for generic Adalat CC
3 June 1999
Elan reacquires generic nifedipine product
28 April 1999
Bayer launches 20mg Adalat
29 March 1999
Generic nifedipine gets tentative FDA approval
29 March 1999
ICAgen To Start Trials Of Three Drugs In 1999
25 November 1998
Bayer Posts Flat Sales For First Nine Months Of 1998
11 November 1998
US Majors Post Strong Earnings For 3rd Quarter
15 October 1998
"Extraordinary"Viagra Sales Lift Pfizer Earnings
10 July 1998
First Launch Of Eisai's Monteplase In Japan
25 June 1998
Bayer Looking At Strong Growth, New Products
18 June 1998
Positive Presentations At Goldman Sachs Conf
15 June 1998
Loss Per Share Narrows At Warner Chilcott
8 May 1998
Latest Wave Of US 1st Quarter Results
7 May 1998
Hypertension: AIIRAs Set To Boom
21 April 1998
Pfizer Posts Double-Digit Sales & Earnings Growth
15 April 1998
Analysts Forecast Bright Outlook For US Majors
8 April 1998
Bayer "Unperturbed" By Wave Of Mergers
18 March 1998
$22 Billion World Drug Delivery Market In 1996
4 March 1998
Trend For 1997 Strong Sales Continues In USA
5 February 1998
Drug Delivery Sales "To Grow 15% A Year To 2005"
4 February 1998
Teva Enters Marketing Deal With Biovail
18 December 1997
Australia Excludes SSRIs From Final TGP Scheme
17 December 1997
Bayer To Invest DM 4bn in Asia Pacific
20 November 1997
Bayer On Track For Record Growth In 1997
13 November 1997
3rd Qtr Net Loss Reduced By 28% At Warner Chilcott
11 November 1997
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
